XML 63 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Apr. 27, 2012
Apr. 29, 2011
OPERATING ACTIVITIES:    
Net income $ 132,322 $ 89,735
Adjustments to reconcile net income to net cash (used in)/provided by operating activities:    
Depreciation 42,917 41,457
Amortization 3,306 3,723
Stock-based compensation 5,710 3,789
(Gain)/loss on asset divestitures 496 (847)
Changes in certain assets and liabilities, net of effects of acquired businesses:    
(Increase)/decrease in accounts and notes receivable (67,109) (63,596)
(Increase)/decrease in inventories and other assets (63,790) (59,890)
Increase/(decrease) in trade accounts payable and other accrued liabilities (32,861) (69,775)
Increase/(decrease) in income taxes payable 831 (1,956)
Increase/(decrease) in other deferred liabilities 9,815 831
Settlement of treasury lock contracts (27,875)  
Other (1,875) (2,346)
Net Cash (Used In)/Provided By Operating Activities 1,887 (58,875)
INVESTING ACTIVITIES:    
Purchases of property, plant and equipment (30,085) (27,405)
Cash proceeds on disposal of assets 2,987 3,379
Acquisition of businesses, net of cash acquired   (30,579)
(Increase)/decrease in restricted cash (931) (189)
Net Cash (Used In)/Provided By Investing Activities (28,029) (54,794)
FINANCING ACTIVITIES:    
Proceeds from issuance of debt 396,816  
Net change in other borrowings (36,376) (51,140)
Net proceeds (repayments) of commercial paper (153,955) 344,903
Proceeds from sale of treasury stock 26,180 27,722
Treasury stock purchases (145,322) (218,643)
Excess tax benefit from stock-based compensation 7,605 5,428
Dividends paid (37,075) (34,483)
Purchase of equity award shares (7,614) (11,454)
Net Cash (Used In)/Provided By Financing Activities 50,259 62,333
Increase/(Decrease) in Cash and Cash Equivalents 24,117 (51,336)
Effect of exchange rate changes on Cash and Cash Equivalents 6,207 3,766
Cash and Cash Equivalents at Beginning of Period 178,167 167,621
Cash and Cash Equivalents at End of Period $ 208,491 $ 120,051